Correlation Between Entrada Therapeutics and Fomo Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Entrada Therapeutics and Fomo Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Entrada Therapeutics and Fomo Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Entrada Therapeutics and Fomo Corp, you can compare the effects of market volatilities on Entrada Therapeutics and Fomo Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Entrada Therapeutics with a short position of Fomo Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Entrada Therapeutics and Fomo Corp.

Diversification Opportunities for Entrada Therapeutics and Fomo Corp

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Entrada and Fomo is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Entrada Therapeutics and Fomo Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fomo Corp and Entrada Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Entrada Therapeutics are associated (or correlated) with Fomo Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fomo Corp has no effect on the direction of Entrada Therapeutics i.e., Entrada Therapeutics and Fomo Corp go up and down completely randomly.

Pair Corralation between Entrada Therapeutics and Fomo Corp

If you would invest  1,598  in Entrada Therapeutics on September 28, 2024 and sell it today you would earn a total of  176.00  from holding Entrada Therapeutics or generate 11.01% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy1.61%
ValuesDaily Returns

Entrada Therapeutics  vs.  Fomo Corp

 Performance 
       Timeline  
Entrada Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.
Fomo Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fomo Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Fomo Corp is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Entrada Therapeutics and Fomo Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Entrada Therapeutics and Fomo Corp

The main advantage of trading using opposite Entrada Therapeutics and Fomo Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Entrada Therapeutics position performs unexpectedly, Fomo Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fomo Corp will offset losses from the drop in Fomo Corp's long position.
The idea behind Entrada Therapeutics and Fomo Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope